GI bleed - Nursing Case Study
Pathophysiology
• Primary mechanism: Mucosal damage leads to GI bleeding through ulcerations or erosions in the stomach or intestinal lining, often due to Helicobacter pylori infection or NSAID use, disrupting the protective mucosal barrier and allowing acid to damage blood vessels.
• Secondary mechanism: Vascular abnormalities, such as varices or angiodysplasia, cause bleeding due to increased pressure or fragile vessel walls, often exacerbated by conditions like portal hypertension in liver cirrhosis, leading to significant hemorrhage risk.
• Key complication: Significant blood loss from a GI bleed can result in hypovolemic shock, with decreased blood perfusion leading to organ failure, making rapid identification and intervention critical to prevent severe morbidity and mortality.
Patient Profile
Demographics:
45-year-old male, construction worker
History:
• Key past medical history: Hypertension, peptic ulcer disease
• Current medications: Lisinopril, omeprazole
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Dark, tarry stools for 3 days
• Key symptoms: Fatigue, dizziness, abdominal pain
• Vital signs: Blood pressure 95/60 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 37.2°C
Section 1
As the clinical team continues to assess the 45-year-old male patient, they note that his vital signs indicate a potential progression towards hypovolemic shock. His blood pressure has dropped further to 88/58 mmHg, his heart rate has increased to 120 bpm, and his skin appears pale and cool to the touch, with noticeable diaphoresis. The patient reports feeling increasingly dizzy and weak, unable to stand without assistance. Despite initial fluid resuscitation efforts with isotonic saline, his symptoms persist, suggesting ongoing blood loss.
To better understand the source and extent of the bleeding, an urgent upper endoscopy is performed. The endoscopy reveals a large, actively bleeding peptic ulcer in the duodenum with visible spurting of blood, confirming the severity of the gastrointestinal bleed. Laboratory results show a hemoglobin level of 7.5 g/dL, significantly lower than the normal range, indicating a substantial loss of blood volume. His hematocrit is also decreased, aligning with the critical drop in hemoglobin.
Given these findings, the healthcare team decides to initiate a blood transfusion to stabilize the patient. They prepare to administer packed red blood cells while simultaneously addressing the bleeding ulcer with endoscopic intervention, such as cauterization or clipping. The combination of these interventions aims to control the bleeding and replenish the patient's blood volume, hopefully preventing further deterioration. As the team monitors the patient's response closely, they remain vigilant for any signs of additional complications, such as rebleeding or infection, which could alter the course of treatment and require further clinical decision-making.
Section 2
As the clinical team administers the blood transfusion and continues endoscopic intervention on the patient's bleeding peptic ulcer, they remain vigilant in monitoring his vital signs and overall status. Initially, the patient shows signs of stabilization; his blood pressure increases to 98/64 mmHg, and his heart rate decreases slightly to 110 bpm. Despite these improvements, the team notices that the patient is not regaining full consciousness, remaining lethargic and disoriented. Furthermore, his urine output has diminished significantly, raising concerns about his renal perfusion and the potential onset of acute kidney injury, a complication often associated with significant blood loss and hypovolemia.
To further evaluate the patient's condition, the team orders additional laboratory tests, including a repeat complete blood count (CBC), basic metabolic panel, and coagulation profile. The CBC indicates that while the hemoglobin level has improved to 8.5 g/dL post-transfusion, it is still below the desired threshold for stabilization. The metabolic panel reveals a rising blood urea nitrogen (BUN) and creatinine level, confirming the suspicion of compromised kidney function. The coagulation profile shows a prolonged prothrombin time (PT), suggesting potential coagulopathy, which could complicate the bleeding control efforts and necessitate further interventions such as administration of fresh frozen plasma or vitamin K.
The clinical team now faces the challenge of addressing these new complications while continuing to manage the primary gastrointestinal bleed. Their focus shifts to optimizing renal perfusion through careful fluid management and considering additional transfusions or pharmacologic interventions to correct the coagulopathy. As they reassess the patient's treatment plan, the team prepares to discuss these developments and potential next steps with the patient’s family, emphasizing the importance of close monitoring and the possibility of further endoscopic or surgical interventions if the bleeding does not resolve.
Section 3
As the clinical team continues to monitor the patient closely, they observe a concerning change in his status. Despite initial stabilization efforts, the patient's blood pressure begins to drop again, now measuring at 85/58 mmHg. His heart rate rises back to 120 bpm, indicating a possible resurgence of hypovolemia and inadequate perfusion. The team notes that his lethargy persists, and he remains disoriented, suggesting that cerebral perfusion may also be compromised. The diminished urine output further raises alarms about worsening renal function, with output now less than 20 mL/hr.
The new set of diagnostic results reveals a troubling trend. The patient's BUN and creatinine levels continue to rise, with BUN now at 45 mg/dL and creatinine at 2.1 mg/dL, confirming acute kidney injury. Meanwhile, the repeat coagulation profile shows further prolongation of PT and a decrease in platelet count to 85,000/mm³, indicating a developing thrombocytopenia. These findings suggest the potential progression to disseminated intravascular coagulation (DIC), complicating the management of his GI bleed.
In response to these developments, the clinical team decides to initiate a more aggressive approach to manage these complications. They opt to administer intravenous fluids cautiously to improve renal perfusion while monitoring for signs of fluid overload. Fresh frozen plasma and platelets are ordered to address the coagulopathy and thrombocytopenia. The team considers the potential need for renal replacement therapy should the patient's renal function continue to deteriorate. Meanwhile, discussions with the patient's family emphasize the critical nature of the situation and the need for vigilant monitoring and possible escalation to surgical intervention if the bleeding remains uncontrolled. These measures aim to stabilize the patient's condition and prevent further complications as they navigate this complex clinical scenario.
Section 4
As the clinical team implements the new interventions, they closely monitor the patient's response to treatment. Initially, there are promising signs: his blood pressure increases slightly to 92/60 mmHg, and his heart rate decreases to 110 bpm. However, the improvement is short-lived. Within a few hours, the patient exhibits respiratory distress, with an increased respiratory rate of 28 breaths per minute and decreased oxygen saturation at 89% on room air. Auscultation of the lungs reveals crackles bilaterally, raising concerns about pulmonary edema as a potential consequence of aggressive fluid administration.
The team promptly reassesses the patient's fluid management strategy, considering the delicate balance between addressing hypovolemia and avoiding fluid overload. Diuretics are cautiously administered to alleviate pulmonary congestion, while oxygen therapy is initiated to support respiratory function. Despite these efforts, the patient’s urine output remains critically low at 15 mL/hr, and his renal function continues to decline, with creatinine rising to 2.5 mg/dL.
Recognizing the gravity of the situation, the team evaluates the necessity of renal replacement therapy. Meanwhile, new laboratory results reveal further deterioration in the patient's coagulation status, with PT extending to 18 seconds and platelet count dropping to 60,000/mm³. These findings necessitate a reassessment of the current bleeding management plan, including the potential escalation to surgical intervention. With the patient's status remaining precarious, the clinical team focuses on optimizing supportive care, considering the interplay of respiratory, renal, and hematologic complications, to stabilize him as they prepare for possible surgical consultation.
Section 5
As the clinical team continues to manage the patient's complex condition, they notice a significant change in his status. Despite the administration of diuretics and oxygen therapy, the patient's respiratory distress worsens. His respiratory rate climbs to 34 breaths per minute, and his oxygen saturation further declines to 85%, even with supplemental oxygen. The increased crackles on lung auscultation suggest worsening pulmonary congestion. Concurrently, the patient exhibits signs of altered mental status, becoming increasingly lethargic and less responsive to verbal stimuli. These changes prompt the team to suspect acute respiratory failure, potentially exacerbated by an ongoing systemic inflammatory response.
In response to these new complications, the team orders a chest X-ray, which reveals bilateral infiltrates consistent with acute pulmonary edema. Recognizing the urgency, they escalate to non-invasive positive pressure ventilation (NIPPV) to improve oxygenation and reduce respiratory effort. The team also decides to initiate continuous renal replacement therapy (CRRT) to address the declining renal function and manage fluid overload more effectively. Meanwhile, they closely monitor the patient's hemodynamic status, as his blood pressure remains low at 88/58 mmHg, with a heart rate of 118 bpm, indicating persistent circulatory compromise.
The clinical team remains vigilant as they navigate the challenges of balancing the patient's respiratory, renal, and hemodynamic needs. They conduct frequent reassessments to evaluate the effectiveness of their interventions and adjust the treatment plan accordingly. With the patient at a critical juncture, the team prepares for a potential surgical consultation, weighing the risks and benefits of a more invasive approach to control the GI bleed in light of the patient's deteriorating condition. Through careful coordination and collaboration, the team aims to stabilize the patient while optimizing supportive care to allow for any necessary procedural interventions.